Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by MERCK

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
005619 New Drug Application Approval
005620 New Drug Application Approval
006668 New Drug Application Approval
007110 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
007750 New Drug Application Approval New formulation (S) Standard review drug
007898 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
008228 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
008472 New Drug Application Approval New formulation (S) Standard review drug
008506 New Drug Application Approval New ester, new salt, or other noncovalent derivative; New combination (P) Priority review drug
009018 New Drug Application Approval New formulation (S) Standard review drug
009193 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
009509 New Drug Application Approval New formulation (P) Priority review drug
010520 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
010562 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
010585 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
010656 New Drug Application Approval New formulation (S) Standard review drug
011028 New Drug Application Approval New formulation (S) Standard review drug
011583 New Drug Application Approval New combination (S) Standard review drug
011635 New Drug Application Approval New combination (S) Standard review drug
011664 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
011835 New Drug Application Approval New manufacturer (S) Standard review drug
011860 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
011958 New Drug Application Approval New manufacturer (S) Standard review drug
011977 New Drug Application Approval New formulation (S) Standard review drug
011983 New Drug Application Approval New formulation (S) Standard review drug
011984 New Drug Application Approval New formulation (S) Standard review drug
012052 New Drug Application Approval New formulation (S) Standard review drug
012071 New Drug Application Approval New formulation (S) Standard review drug
012376 New Drug Application Approval New formulation (S) Standard review drug
012383 New Drug Application Approval New combination (S) Standard review drug
012649 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
012731 New Drug Application Approval New formulation (S) Standard review drug
013220 New Drug Application Approval New formulation (S) Standard review drug
013334 New Drug Application Approval New combination (S) Standard review drug
013400 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
013401 New Drug Application Approval New ester, new salt, or other noncovalent derivative (P) Priority review drug
013402 New Drug Application Approval New combination (S) Standard review drug
013538 New Drug Application Approval New formulation (S) Standard review drug
016016 New Drug Application Approval New combination (S) Standard review drug
016675 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
017911 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
018017 New Drug Application Approval New formulation (P) Priority review drug
018061 New Drug Application Approval New combination (S) Standard review drug
018201 New Drug Application Approval New combination (S) Standard review drug
018389 New Drug Application Approval New formulation (S) Standard review drug
018445 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
019384 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
019510 New Drug Application Approval New formulation (S) Standard review drug
019558 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019643 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
019757 New Drug Application Approval New formulation (S) Standard review drug
019766 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019778 New Drug Application Approval New combination (S) Standard review drug
020180 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020408 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020506 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
020752 New Drug Application Approval New formulation (S) Standard review drug
020788 New Drug Application Approval New formulation (S) Standard review drug
020829 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020830 New Drug Application Approval New formulation (S) Standard review drug
020864 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020865 New Drug Application Approval New formulation (S) Standard review drug
021042 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
021052 New Drug Application Approval New formulation (P) Priority review drug
021227 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
021409 New Drug Application Approval New formulation (S) Standard review drug
021549 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
021575 New Drug Application Approval New formulation (S) Standard review drug
021647 New Drug Application Approval New indication (S) Standard review drug
021762 New Drug Application Approval New combination (S) Standard review drug
021991 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
050322 New Drug Application Approval
050324 New Drug Application Approval
050378 New Drug Application Approval
050581 New Drug Application Approval New formulation (S) Standard review drug
050587 New Drug Application Approval New molecular entity (NME); New combination (P) Priority review drug
050630 New Drug Application Approval New formulation (S) Standard review drug
062756 Abbreviated New Drug Application Approval
080778 Abbreviated New Drug Application Approval
101063 Biologic License Application Approval

Back to Companies who have applied for FDA Drug Approval


 

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.